human

(redirected from coagulation factor IX)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.
Related to coagulation factor IX: coagulation factor VIII

human

noun being, body, character, human being, individual, living soul, man, member of the human race, one, particular one, party, person, woman
Associated concepts: human rights law, United NationsDeclaration of Human Rights
See also: bodily, character, person, physical
References in periodicals archive ?
Efficacy and safety results of PROLONG-9FP clinical program of recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in previously treated patients with hemophilia B.
We manufactured the coagulation factor IX (recombinant) drug substance for all of the clinical trials.
Wyeth currently markets the only recombinant Factor IX product, BeneFIX(R) Coagulation Factor IX (Recombinant).
The study Coagulation Factor IX (CAS 9001-28-9) Market Research Report 2011' presents an overview of the Coagulation Factor IX market globally and regionally by contemplating and analyzing its parameters.
Contract notice: Concentrate osoczopochodnego coagulation factor ix delivered to your door patient / do haemophilia center; investigation sign: zzp-140/15.
March 30, 2015 /PRNewswire/ -- CSL Behring announced today that the European Medicines Agency (EMA) has started the Centralized Procedure for reviewing the company's Marketing Authorization Application (MAA) for its long-acting fusion protein linking recombinant coagulation factor IX with recombinant albumin (rIX-FP).
The 'Coagulation Factor IX (CAS 9001-28-9) Market Research Report 2010' presents an overview of the Coagulation Factor IX market globally and regionally, with an analysis of its parameters.
Food and Drug Administration (FDA) has accepted for review its Biologics License Application (BLA) for the marketing authorization of its long-acting fusion protein linking recombinant coagulation factor IX with recombinant albumin (rIX-FP).
Supply of coagulation Factor IX (DOE) and Insulin human (DOE) soluble.
16, 2014 /PRNewswire/ -- CSL Behring announced today it has submitted a biologics license application (BLA) to the United States Food and Drug Administration (FDA) for the marketing authorization of its long-acting fusion protein linking recombinant coagulation factor IX with recombinant albumin (rIX-FP).
Among the programs are those involving Beta Interferon, G-CSF, Parathyroid Hormone, EGF, the various forms of FGF (1 to 22), and pegylated versions of Interferon Alpha, hGH, C-CSF, Beta Interferon, EPO, Coagulation Factor VIII, Coagulation Factor IX, FGF-1, Interferon Gamma, Interleukin-12, and Insulin-Like Growth Factor-1.